Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 981 $ 722
Restricted cash 2,175 1,880
Accounts and other receivables 581 369
Accounts receivable—related party 4 2
Inventory 316 243
Derivative assets 63 57
Other current assets 114 96
Total current assets 4,234 3,369
Non-current restricted cash 0 11
Property, plant and equipment, net 27,245 23,978
Debt issuance costs, net 72 149
Non-current derivative assets 54 34
Goodwill 77 77
Other non-current assets, net 305 288
Total assets 31,987 27,906
Current liabilities    
Accounts payable 58 25
Accrued liabilities 1,169 1,078
Current debt 239 0
Deferred revenue 139 111
Derivative liabilities 128 37
Other current liabilities 9 0
Total current liabilities 1,742 1,251
Long-term debt, net 28,179 25,336
Non-current capital lease obligations 57 0
Non-current derivative liabilities 22 19
Other non-current liabilities 58 60
Commitments and contingencies (see Note 19)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued 0 0
Common Stock, $0.003 par value, Authorized: 480.0 million shares at December 31, 2018 and 2017; Issued: 269.8 million shares and 250.1 million shares at December 31, 2018 and 2017, respectively
Outstanding: 257.0 million shares and 237.6 million shares at December 31, 2018 and 2017, respectively 1 1
Treasury stock: 12.8 million shares and 12.5 million shares at December 31, 2018 and 2017, respectively, at cost (406) (386)
Additional paid-in-capital 4,035 3,248
Accumulated deficit (4,156) (4,627)
Total stockholders’ deficit (526) (1,764)
Non-controlling interest 2,455 3,004
Total equity 1,929 1,240
Total liabilities and equity $ 31,987 $ 27,906